SGRT-based DIBH radiotherapy practice for right breast cancer combined with RNI: A retrospective study on dosimetry and treatment accuracy

Author:

Lai Jianjun1,Hu Haili1,Jiang Lu1,Wu Jing1,Lei Lan1,Zhang Chuanfeng1,Jing Zhao1,Qu Li1,Wu Zhibing1

Affiliation:

1. Zhejiang Hospital

Abstract

Abstract Background: This paper studied retrospectively the dosimetry and therapeutic accuracy of deep inspiration breath hold (DIBH) radiotherapy in regional nodal radiation (RNI)-containing right-sided breast cancer patients who had completed treatment based on surface guided radiotherapy (SGRT) technology, hoping to clarify the clinical application value and related issues . Methods: Free breath (FB) and DIBH plans were prepared for31 RNI-containing right breast cancer patients who had completed DIBH radiotherapy based on SGRT technology. Four organs at risk (OARs) including heart, right coronary artery (RCA), right lung and liver were made dosimetriccomparison on the premise that the planning target volume was met dose-volume prescription requirements. Meanwhile, 31 patients were divided into edge of xiphoid process (EXP), sternum middle (SM)and left breast wall (LBW) groups according to different positions of respiratory gating primary points. The CBCT setup error data of the three groups were contrasted for the treatment accuracy study, and the effects of different gating window heights on the lung volume increment of the right side were compared among the three groups. Results: All planning target volume met the dose-volume coverage criteria. Compared with FB, DIBH slumpedthe maximum dose of heart and RCA by 44.3% and 46.7% respectively. The mean dose was went down by 12.5% for right lung. The mean liver dosedecreased the most, with an average reduction rate of 69.4%. The setup error of EXP group in the anterior-posterior (AP) direction was 3.6±4.5mm, significantly higher than the other two groups (2.2±2.6mm, 2.4±3.1mm). The rightlung volume increment in EXP, SM and LBW groups was 72.3%, 69.9 % and 67.2%, respectively(P=0.08), and the corresponding breath-holding heights were 13.5±3.7mm, 10.3±2.4mm, and 9.6±2.8mm, respectively(p<0.05). Conclusions: SGRT-based DIBH can better protect the heart, RCA, ipsilateral lung and liver of right breast cancer patients combined with RNI. Different respiratory gating primary points have different therapeutic accuracy and breath-hold height. On the premise of reasonable respiratory gating primary points, interfractions can be widely applied as it has high repeatability and breath-holding stability to ensure therapeutic accuracy.

Publisher

Research Square Platform LLC

Reference47 articles.

1. Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020;Lei S;Cancer Commun (Lond),2020

2. Cancer statistics2022.CA:A Cancer;Siegel RL;J Clin,2022

3. Global Cancer Statistics2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA:A Cancer Journal for Clinicians,2021

4. Loibl S, Poortmans P, Morrow M. et al Breast cancer Lancet. 2021;397:1750–69.

5. Systemic treatment and radiotherapy, breast cancer subtypes,and survival after long-term clinical follow-up;Yang SX;Breast Cancer Res Treat,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3